Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Germany

G-BA's Decision Not To Reimburse Plavix Will Stand

April 2008 | Industry News

Germany's Federal Joint Committee on Healthcare (G-BA) has confirmed that it will not reimburse Plavix (clopidogrel) as a prophylactic treatment for cardiovascular disease. The decision comes as a result of findings by the Institute for Quality and Efficiency in Healthcare (IQWiG) in 2007 that Plavix had no real benefit over Aspirin when used as secondary

To read the full article, please choose one of the following options:

Subcribers please log in

Western Europe InsightWestern Europe Channels Western Europe Countries